Novità nel mondo di Medicina di Laboratorio

The Week That Wasn't: CRISPR Prime, New Flu Drug, Calm Brain for Long Life

Pathology & Lab Medicine - Medscape - Gio, 31/10/2019 - 14:23
Three medical stories that we didn't cover, explained.
Medscape

Visual Dysfunction: An Underrecognized Symptom of Parkinson's?

Pathology & Lab Medicine - Medscape - Gio, 31/10/2019 - 14:23
A large health survey has that found visual problems are more than twice as common in individuals with Parkinson's compared to the general population.
Medscape Medical News

Top 5 Patient Safety Risks in Ambulatory Care

Pathology & Lab Medicine - Medscape - Gio, 31/10/2019 - 14:23
Errors in diagnostic testing and medication, falls, privacy violations, and disruptive patients top ECRI's list of biggest patient safety concerns in outpatient care settings.
Medscape Medical News

'Intriguing Changes' in Gut Bacteria After MS Treatment

Pathology & Lab Medicine - Medscape - Gio, 31/10/2019 - 14:23
Significant changes in gut bacteria were observed in patients with multiple sclerosis within a month of treatment with ocrelizumab, a small, ongoing study reports.
Medscape Medical News

Sharing Stories Connects Clinicians to Each Other, Patients

Pathology & Lab Medicine - Medscape - Mer, 30/10/2019 - 13:23
One care team has launched Good Grief Rounds, using storytelling to debrief emotionally difficult cases, and others are using literature to foster empathy and engagement in the practice of medicine.
Medscape Medical News

In Older Women With DCIS, Skip Lymph Node Biopsy

Pathology & Lab Medicine - Medscape - Mer, 30/10/2019 - 13:23
A new analysis shows that the extra step of performing lymph node biopsy has no benefits but may cause harm in older women with ductal carcinoma in situ (DCIS).
Medscape Medical News

One Third of CVD in US Blacks Linked to Hypertension

Pathology & Lab Medicine - Medscape - Mer, 30/10/2019 - 13:23
New data highlight the need for more focused efforts to diagnose and treat hypertension and prevent its development in the black population.
Medscape Medical News

Albumin Index May Predict Severity, Disability in Neurosarcoidosis

Pathology & Lab Medicine - Medscape - Mer, 30/10/2019 - 13:23
With biomarkers for disease severity in neurosarcoidosis lacking, clinical utility may be found with the albumin index, a measure of blood-brain barrier permeability, new research suggests.
Medscape Medical News

BEACON Trial in BRAF-Mutant mCRC: Now Published, Criticized

Pathology & Lab Medicine - Medscape - Mer, 30/10/2019 - 13:23
Showing a survival advantage for targeted therapy over chemotherapy, this trial has been hailed as practice changing, but it has now also been criticized for lack of detail.
Medscape Medical News

Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes [Review]

Clinical Chemistry - Ultimo numero - Mar, 29/10/2019 - 17:00
BACKGROUND:

For medical tests that have a central role in clinical decision-making, current guidelines advocate outcome-based analytical performance specifications. Given that empirical (clinical trial-style) analyses are often impractical or unfeasible in this context, the ability to set such specifications is expected to rely on indirect studies to calculate the impact of test measurement uncertainty on downstream clinical, operational, and economic outcomes. Currently, however, a lack of awareness and guidance concerning available alternative indirect methods is limiting the production of outcome-based specifications. Therefore, our aim was to review available indirect methods and present an analytical framework to inform future outcome-based performance goals.

CONTENT:

A methodology review consisting of database searches and extensive citation tracking was conducted to identify studies using indirect methods to incorporate or evaluate the impact of test measurement uncertainty on downstream outcomes (including clinical accuracy, clinical utility, and/or costs). Eighty-two studies were identified, most of which evaluated the impact of imprecision and/or bias on clinical accuracy. A common analytical framework underpinning the various methods was identified, consisting of 3 key steps: (a) calculation of "true" test values; (b) calculation of measured test values (incorporating uncertainty); and (c) calculation of the impact of discrepancies between (a) and (b) on specified outcomes. A summary of the methods adopted is provided, and key considerations are discussed.

CONCLUSIONS:

Various approaches are available for conducting indirect assessments to inform outcome-based performance specifications. This study provides an overview of methods and key considerations to inform future studies and research in this area.

In Silico Analysis of Gardnerella Genomospecies Detected in the Setting of Bacterial Vaginosis [Infectious Disease]

Clinical Chemistry - Ultimo numero - Mar, 29/10/2019 - 17:00
BACKGROUND:

Gardnerella vaginalis is implicated as one of the causative agents of bacterial vaginosis, but it can also be isolated from the vagina of healthy women. Previous efforts to study G. vaginalis identified 4 to 6 clades, but average nucleotide identity analysis indicates that G. vaginalis may be multiple species. Recently, Gardnerella was determined to be 13 genomospecies, with Gardnerella piottii, Gardnerella leopoldii, and Gardnerella swidsinkii delineated as separate species.

METHODS:

We accessed 103 publicly available genomes annotated as G. vaginalis. We performed comprehensive taxonomic and phylogenomic analysis to quantify the number of species called G. vaginalis, the similarity of their core genes, and their burden of their accessory genes. We additionally analyzed publicly available metatranscriptomic data sets of bacterial vaginosis to determine whether the newly delineated genomospecies are present, and to identify putative conserved features of Gardnerella pathogenesis.

RESULTS:

Gardnerella could be classified into 8 to 14 genomospecies depending on the in silico classification tools used. Consensus classification identified 9 different Gardnerella genomospecies, here annotated as GS01 through GS09. The genomospecies could be readily distinguished by the phylogeny of their shared genes and burden of accessory genes. All of the new genomospecies were identified in metatranscriptomes of bacterial vaginosis.

CONCLUSIONS:

Multiple Gardnerella genomospecies operating in isolation or in concert with one another may be responsible for bacterial vaginosis. These results have important implications for future efforts to understand the evolution of the Gardnerella genomospecies, host–pathogen interactions of the genomospecies during bacterial vaginosis, diagnostic assay development for bacterial vaginosis, and metagenomic investigations of the vaginal microbiota.

Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors [Endocrinology and Metabolism]

Clinical Chemistry - Ultimo numero - Mar, 29/10/2019 - 17:00
BACKGROUND:

Currently, several indole markers are measured separately to support diagnosis and follow-up of patients with neuroendocrine tumors (NETs). We have developed a sensitive mass spectrometry method that simultaneously quantifies all relevant tryptophan-related indoles (tryptophan, 5-hydroxytryptophan, serotonin, 5-hydroxyindoleacetic acid) in platelet-rich plasma. Direct-matrix derivatization was used to make the chemical properties of the indoles uniform and to improve the analytical sensitivity and specificity of the assay.

METHODS:

In situ derivatization was performed directly in platelet-rich plasma with propionic anhydride at an ambient temperature. The derivatized indoles were extracted by online solid-phase extraction and eluted to the analytical column for separation followed by mass spectrometric detection. The method was validated according to international guidelines. Platelet-rich plasma samples from 68 healthy individuals and 40 NET patients were analyzed for tryptophan, 5-hydroxytryptophan, serotonin, and 5-hydroxyindoleacetic acid.

RESULTS:

The method reproducibly quantified relevant indoles in 8.5 min, including online sample cleanup. Intra- and interassay imprecision, evaluated at 3 different concentrations, ranged from 2.0% to 12% and 1.9% to 13%, respectively. The limit of quantification was sufficient to measure endogenous concentrations of all 4 indoles. Healthy individuals and NET patients had different concentrations of 5-hydroxytryptophan, serotonin, and 5-hydroxyindoleacetic acid, but tryptophan concentrations were the same.

CONCLUSIONS:

Direct-matrix derivatization in combination with LC-MS/MS is a powerful tool for the simultaneous quantification of all tryptophan-related indoles in platelet-rich plasma. Simultaneous profiling of relevant indoles improves the biochemical characterization and follow-up of NETs.

An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results [Endocrinology and Metabolism]

Clinical Chemistry - Ultimo numero - Mar, 29/10/2019 - 17:00
BACKGROUND:

Measurement of plasma adrenocorticotropic hormone (ACTH) is key in the differential diagnosis of hypothalamic-pituitary-adrenal disorders. Two-site sandwich immunoassays dominate clinical testing of ACTH in North America; however, discordant results between manufacturers have been repeatedly reported. To resolve the discrepancy, we developed a liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay for the intended measurand, biologically active intact ACTH (iACTH).

METHODS:

The multiple reaction monitoring LC-MS/MS assay was designed to selectively measure full-length iACTH, as well as ACTH analogs and fragments (i.e., ACTH1–24 and ACTH18–39). Epitope assignment of the Roche Elecsys antibodies was performed by MALDI-TOF mass spectrometry. A method comparison between Roche Elecsys and Siemens Immulite ACTH immunoassays was performed and clinically concordant/discordant results identified. In a subset of these samples, the iACTH concentration was determined using the LC-MS/MS method.

RESULTS:

The lower limit of the measuring interval of the iACTH LC-MS/MS assay was 9 pg/mL (2 pmol/L). The assay was linear from 9 to 1938 pg/mL (2 to 427 pmol/L). Epitope mapping revealed that the Roche capture and detection antibodies bound residues 9–12 and 36–39 of ACTH, respectively. The iACTH LC-MS/MS analysis demonstrated that for discordant results between 2 immunoassays studied, only the Roche results were highly positively correlated with the iACTH concentration.

CONCLUSIONS:

Immunoprecipitation of biologically active ACTH molecules followed by LC-MS/MS analysis enabled selective detection of iACTH and relevant biologically active fragments in plasma. Applied to the investigation of clinically discrepant results, this method can act as an arbiter of the concentration of iACTH present.

Condividi contenuti